Glycos Biotechnologies to Present at BIO’s Seventh Annual World Congress on Industrial Biotechnology and Bioprocessing
HOUSTON, TX – June 29, 2010 – Glycos Biotechnologies, Inc. (GlycosBio), an emerging biochemical company pioneering metabolic engineering and microbiology innovations to produce sustainable biochemicals, is presenting at BIO’s World Congress on Industrial Biotechnology and Bioprocessing taking place June 28th – 30th in Washington, DC.
Paul Campbell, Chief Science Officer for GlycosBio, will participate in a panel with other leading biotechnology scientists discussing the advances in fermentation and bioprocesses. Campbell will present about GlycosBio’s microbial technology and its unique ability to convert non-sugar carbon sources such as glycerin into high value chemicals including technical grade alcohols, acetone, isoprene, succinc acid, diols and lactic acid.
BIO’s World Congress on Industrial Biotechnology and Bioprocessing is a unique interdisciplinary forum presenting the latest developments in biotechnology for biofuels, renewable chemicals, biobased materials, and biotech-based manufacturing and processing. In its seventh year, the event will explore ways that public policy can help drive innovation and the commercialization of industrial biotechnology and bioprocessing.
What: “Advanced Biofuel Technologies: Advances in Fermentation”
Who: Paul Campbell, PhD., Chief Science Officer, Glycos Biotechnologies
Jan de Bont, Manager, Research & Development, Royal Nedalco
Kevin Gray, Senior Vice President and Chief Technology Officer, Qteros
Where: Gaylord Resort & National Convention Center, Washington, DC.
When: Tuesday, June 29th, 9:00am – 10:30am
For more information about the 2010 World Congress on Industrial Biotechnology and Bioprocessing, visit http://www.bio.org/worldcongress.
About Glycos Biotechnologies, Inc.
Glycos Biotechnologies, Inc. (GlycosBio) is an emerging biochemical company pioneering the metabolic engineering of microbial strains to consume multiple non sugar-based, low value feedstocks for the production of sustainable chemicals and advanced ethanol. By designing differentiated microorganisms, GlycosBio’s bioconversion technology lowers production cost and provides a non food energy balance savings to the chemical and biofuel industries. GlycosBio is privately held with established global relationships focused on product commercialization. For more information, visit www.glycosbio.com.